Evidence map›Paper›PMID 25889116›Full record

ArticleBMC pharmacology & toxicology2015

Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance.

Abeer Abuzeid Atta Elmannan, Khalid Abdelmutalab Elmardi, Yassir Ali Idris, Jonathan M Spector, Nahid Abdelgadir Ali, Elfatih Mohamed Malik

Open access · goldAbstract read
In one paragraph

Article in BMC pharmacology & toxicology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Abeer Abuzeid Atta ElmannanAl Neelain University, Steen Street, P.O. Box 7294, Code: 11123, Khartoum, Sudan. abeeratta@gmail.com.
Khalid Abdelmutalab ElmardiFederal Ministry of Health, Khartoum, Sudan. khalid.elmardi@gmail.com.
Yassir Ali IdrisGezira State Ministry of Health, Wad Medani, Sudan. yassir.idris@gmail.com.
Jonathan M SpectorHarvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. spectorjm@gmail.com.
Nahid Abdelgadir AliFederal Ministry of Health, Khartoum, Sudan. nahid100@hotmail.com.
Elfatih Mohamed MalikGezira State Ministry of Health, Wad Medani, Sudan. fatihmmalik@gmail.com.
Federal Ministry of Health · SDUniversity of Gezira · SDAl-Neelain University · SDHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe World Health Organization (WHO) recommends artemisinin-based combination therapies (ACTs) as first-line treatment for uncomplicated malaria. Sudan revised its malaria treatment policy accordingly in 2004. However, eight years after ACTs were introduced in Sudan the patterns of ACT prescribing practices among health care providers remain unclear. We systematically analyzed use of ACTs in a large number of primary health facilities and we discuss the public health implications of our findings.

methodsThis cross-sectional study was based on WHO's guidance for investigating drug use in health facilities. Data were collected from 40 randomly selected primary health centers in five localities in Gezira State, Sudan. The primary outcome of the study was the proportion of patients who were adequately managed according to Sudan's recommended malaria treatment guidelines. Twelve drug-use indicators were used to assess key ACT prescribing practices.

resultsOne thousand and two hundred patients diagnosed with uncomplicated malaria were recruited into the study. ACT was prescribed for 88.6%patients and artemether injections were (incorrectly) prescribed in 9.5% of cases. Only 40.9% of patients in the study were correctly diagnosed and 26.9% were adequately managed according to the nationally recommended treatment guidelines. Incorrect prescribing activities included failure to use generic medicine names (88.2%), incorrect dosage (27.7%), and unexplained antibiotic co-prescription (24.2%). Dispensing practices were also poor, with labeling practices inadequate (97.1%) and insufficient information given to patients about their prescribed treatment (50.5%).

conclusionIrrational malaria treatment practices are common in Sudan. This has important public health implications since failure to adhere to nationally recommended guidelines could play a role in the future development of drug resistance. As such, identifying ways to improve the anti-malarial prescribing practices of heath workers in Sudan may be a priority.

Indexed as

Drug ResistanceAntimalarialsArtemisininsCross-Sectional StudiesDrug Therapy, CombinationHumansMalariaMedication ErrorsPractice Patterns, Physicians'SudanAntimalarialsartemisininArtemisinins

Identifiers

PMID25889116
PMCPMC4377183
OpenAlexW1997543935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.